Drug-labels.com

Ava-Pravastatin: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Post Market
Strength:
10 mg, 20 mg, 40 mg
Active ingredient:

Patient Medication Information: uses, side effects, how to take - Ava-Pravastatin

ABOUT THIS MEDICATION

What the medication is used for:

AVA-PRAVASTATIN (pravastatin sodium) is available only with your physician’s prescription. It is to be used as an adjunct to a medically recommended and carefully supervised diet for the long-term treatment of hypercholesterolemia and is not a substitute for such a diet. This has been shown to decrease the chances of experiencing a first or second heart attack, or stroke, and may help prevent heart disease if caused by cholesterol clogging the blood vessels, or slow the progression of atherosclerosis (hardening) of the arteries that nourish your heart, so-called coronary heart disease (CHD). In addition, depending on your condition, your physician may recommend an appropriate regimen of exercise, weight control and other measures.

What it does:

AVA-PRAVASTATIN lowers the level of cholesterol, particularly Low Density Lipoprotein (LDL) cholesterol, in the blood. AVA-PRAVASTATIN reduces cholesterol production by the liver and induces some changes of cholesterol transport and disposition in the blood and tissues.

When it should not be used:

  • If you are pregnant, since its use in the event of

    pregnancy may harm the unborn. Only female patients who are highly unlikely to conceive can be candidates for AVA-PRAVASTATIN treatment. In the event of pregnancy during treatment, AVA-PRAVASTATIN should be discontinued and physician informed.

  • If you know you are allergic to pravastatin or any of the

    non-medicinal ingredients of AVA-PRAVASTATIN.

  • If you have liver disease

    • In adolescents and children since the safety of AVA-

      PRAVASTATIN in this age group has not been established.

What the medicinal ingredient is:

Pravastatin sodium

What the important nonmedicinal ingredients are:

Non-medicinal ingredients: croscarmellose sodium, lactose monohydrate, magnesium stearate and microcrystalline cellulose.

Colourants are present in the tablets as follows:

10 mg tablet: red ferric oxide

20 mg tablet: yellow ferric oxide

40 mg tablet: D&C yellow #10 and FD&C blue #1

What dosage forms it comes in:

10, 20 and 40 mg tablets

WARNINGS AND PRECAUTIONS

Use only as specifically directed. Do not alter the dosage unless ordered to do so by your physician. Check with your physician before discontinuing medication since this may result in an increase of your blood lipids.

Before starting AVA-PRAVASTATIN, tell your doctor or pharmacist if you:

  • Are breast-feeding or intend to breast feed,
  • Have thyroid problems
  • Have a family history of muscular disorders
  • Had any past problems with muscles (pain, tenderness), after using an HMG-CoA reductase inhibitor (“statin”) such as atorvastatin (Lipitor®)1, fluvastatin (Lescol®)2, lovastatin (Mevacor®)3, pravastatin (Pravachol®)4, rosuvastatin (Crestor®)5 or simvastatin (Zocor®)3, or have developed an allergy or intolerance to them.
  • Have kidney or liver problems,
  • Diabetes,
  • Have undergone surgery or other tissue injury,
  • Do excessive physical exercise.

1 Lipito® is a registered trademark of Pfizer Ireland Pharmaceuticals. 2 Lescol® is a registered trademark of Sandoz Canada Inc.

3 Mevacor® & Zocor® are registered trademarks of Merck & Co., Inc. 4 Pravachol® is a registered trademark of Bristol-Myers Squibb company Inc. 5 Crestorl® is a registered trademark of IPR Pharmaceuticals Inc.

Pregnancy

Before using this medication, discuss the following with your doctor:

  • Cholesterol compounds are essential elements for the

    development of the fetus.

  • Cholesterol-lowering drugs can harm the fetus. If

    you are of child-bearing age, discuss with your doctor the potential hazards to the fetus and the importance of birth control methods

  • AVA-PRAVASTATIN should not be used by

    pregnant women. If you become pregnant, discontinue use immediately and discuss with your doctor.

INTERACTIONS WITH THIS MEDICATION

AVA-PRAVASTATIN may interact with other drugs, including those you take without prescription. You must tell you doctor or pharmacist about all drugs, including prescription and non-prescription, herbal products and supplements, you are taking or planning to take before you take AVA-PRAVASTATIN.

You should tell your doctor if you are taking other cholesterol lowering medication such as fibrates (gemfibrozil, fenofibrate), niacin or ezetimibe. If you take these drugs and AVA-PRAVASTATIN together you may be at increased risk of myopathy (muscle disease with aching or weakness).

If you are taking a bile acid-binding resin (such as cholestyramine, colestipol), your doctor will recommend that you take AVA-PRAVASTATIN either one hour or more before or at least four hours following the resin. Taking them together causes lower amounts of AVA-PRAVASTATIN in the blood, making it less effective.

If you are taking cyclosporine, your doctor may need to adjust the dose of AVA-PRAVASTATIN.

Excessive alcohol intake should be avoided when taking AVA-PRAVASTATIN. Tell your doctor if you regularly drink three or more alcoholic drinks daily.

PROPER USE OF THIS MEDICATION

  • Do not change the dose unless directed by a doctor.
  • AVA-PRAVASTATIN should be taken as a single dose

    at bedtime, as prescribed by your physician.

  • Your physician will monitor your clinical condition and

    your blood tests at regular intervals. It is important to have these check-ups done on schedule. Please keep your appointments accurately.

  • Notify your physician about any illness which may

    develop during your treatment with AVA-PRAVASTATIN and about any new prescriptions or non-prescription medication you take. If you require

    medical help for other reasons, inform the attending physician that you are taking AVA-PRAVASTATIN.

    • Notify your physician if you are going to have major surgery or have sustained a severe injury.
    • Notify your physician of any muscle pain, tenderness or weakness developing during treatment with AVA-PRAVASTATIN. (see SIDE EFFECTS ).

Usual dose:

The recommended starting dose is 20 mg once daily at bedtime. Patients who require a large reduction in LDL-C may be started at 40 mg once daily. The dose of 80 mg once daily should be reserved for patients who do not achieve their treatment goal with lower doses. AVA-PRAVASTATIN may be taken without regard to meals.

Overdose:

There is no specific recommended therapy for overdose with AVA-PRAVASTATIN.

In case of overdose, contact your doctor immediately or go to the nearest hospital emergency room.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Along with its intended action, any medication may cause unwanted effects.

Check with your physician as soon as possible if any of the following side effects occurs: aching muscles, muscle cramping, tiredness or weakness, fever and blurred vision.

Muscle Effects

Side effects such as myalgia (muscle pain), myopathy (muscle disease with aching or weakness), rhabdomyolosis (a muscle wasting disease), associated tenderness, and rare cases of rhabdomyolosis leading to kidney failure have been reported with other drugs of this class known as HMG-CoA reductase inhibitors (“statins”), including AVA-PRAVASTATIN.

As these muscle problems are on rare occasions serious, you should contact your physician promptly if you experience any of the side effects listed in the Table below.

Possible side effects reported with some statins: breathing problems including persistent cough and/ or shortness of breath or fever, mood problems including depression, problems sleeping including insomnia and nightmares and sexual problems.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY
HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effectTalk with your doctor or pharmacistStop taking drug and call your doctor or pharmacist
Only if severeIn all cases
Rare

-muscle pain that you cannot explain

-muscle tenderness or muscle weakness

-generalized

weakness, especially if you do not feel well (ie. fever or fatigue)

-brownish or

discoloured urine

Ã

Ã

Ã

Ã

Other side effects may occasionally occur which usually do not require stopping treatment. They may come and go during treatment without any particular danger, but you should mention them to your physician, without undue delay, if the become persistent or bothersome. Such adverse experiences include abdominal pain, constipation, diarrhea, nausea, headache, dizziness, and skin rashes.

This is not a complete list of side effects. For any unexpected effects while taking AVA-PRAVASTATIN, contact your doctor or pharmacist.

HOW TO STORE IT

AVA-PRAVASTATIN should be stored at room temperature (15-30°C). Protect from moisture and light.

REPORTING SUSPECTED SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

  • Report online at www.healthcanada.gc.ca/medeffect ③ Call toll-free at 1-866-234-2345
  • Complete a Canada Vigilance Reporting Form and:

    • Fax toll-free to 1-866-678-6789, or
    • Mail to : Canada Vigilance Program

      Health Canada

      Address Locator: 0701D

      Ottawa, ON K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffectTM Canada Web site at www.healthcnada.gc.ca/medeffect.

NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

For more information, please contact your doctor, pharmacist or other healthcare professional.

This leaflet plus the full product monograph, prepared for health professionals, can be obtained by contacting the sponsor, Avanstra Inc. at:

1-855-708-3678 or medinfo@avanstra.com

Last revised: February 21, 2011

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02364417

Revision date stated in the text: February 21, 2011

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Ava-Pravastatin

Rx or OTC
Prescription (Rx)?
DIN 02364417, 02364425, 02364433
Schedule(s) PRESCRIPTION
Active ingredient(s) Pravastatin sodium
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. C Cardiovascular system drugs
    1. C10 Lipid modifying agents
      1. C10A Lipid modifying agents, plain
        1. C10AA HMG CoA reductase inhibitors, plain lipid modifying drugs
          1. C10AA03 Pravastatin
Company AVANSTRA INC
Current status Cancelled Post Market
Current status date December 12, 2011
Strengths and forms
DIN Strength Dosage form(s) Current status
02364417 10 MG Tablet Cancelled Post Market December 12, 2011
02364425 20 MG Tablet Cancelled Post Market December 12, 2011
02364433 40 MG Tablet Cancelled Post Market December 12, 2011

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.